NO981241L - Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse - Google Patents

Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse

Info

Publication number
NO981241L
NO981241L NO981241A NO981241A NO981241L NO 981241 L NO981241 L NO 981241L NO 981241 A NO981241 A NO 981241A NO 981241 A NO981241 A NO 981241A NO 981241 L NO981241 L NO 981241L
Authority
NO
Norway
Prior art keywords
optionally substituted
derivatives
pharmaceutical preparations
preparations containing
heteroaryl substituted
Prior art date
Application number
NO981241A
Other languages
English (en)
Norwegian (no)
Other versions
NO981241D0 (no
Inventor
Kazumi Kikuchi
Akira Toyoshima
Toshio Okazaki
Masahiro Takanashi
Isao Yanagisawa
Original Assignee
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Pharma Co Ltd filed Critical Yamanouchi Pharma Co Ltd
Publication of NO981241D0 publication Critical patent/NO981241D0/no
Publication of NO981241L publication Critical patent/NO981241L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81Amides; Imides
    • C07D213/82Amides; Imides in position 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/325Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • C07D207/327Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36Compounds containing methylenedioxyphenyl groups, e.g. sesamin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO981241A 1995-09-20 1998-03-19 Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse NO981241L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP24171695 1995-09-20
PCT/JP1996/002696 WO1997011055A1 (en) 1995-09-20 1996-09-19 Heteroaryl-substituted acryloylguanidine derivatives and medicinal composition thereof

Publications (2)

Publication Number Publication Date
NO981241D0 NO981241D0 (no) 1998-03-19
NO981241L true NO981241L (no) 1998-05-20

Family

ID=17078479

Family Applications (1)

Application Number Title Priority Date Filing Date
NO981241A NO981241L (no) 1995-09-20 1998-03-19 Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse

Country Status (13)

Country Link
EP (1) EP0861831A4 (cs)
KR (1) KR19990063589A (cs)
CN (1) CN1196721A (cs)
AU (1) AU702092B2 (cs)
BR (1) BR9610530A (cs)
CA (1) CA2232497A1 (cs)
CZ (1) CZ84098A3 (cs)
HU (1) HUP9901336A3 (cs)
NO (1) NO981241L (cs)
PL (1) PL326033A1 (cs)
SK (1) SK35198A3 (cs)
WO (1) WO1997011055A1 (cs)
ZA (1) ZA967800B (cs)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0854721B1 (en) * 1995-08-02 2001-10-24 Smithkline Beecham Corporation Endothelin receptor antagonists
US6258829B1 (en) * 1997-03-06 2001-07-10 Toa Eiyo Ltd. Cycloalka[b]pyridine-3-carbonylguanidine derivatives, process for producing the same, and drugs containing the same
HK1047928A1 (zh) * 1999-08-23 2003-03-14 Smithkline Beecham Corporation 脂肪酸合成酶抑制剂
DE60123665T2 (de) 2000-12-26 2007-08-16 Sankyo Co., Ltd. Medizinische zusammensetzungen mit diuretischem und die insulinresistenz verbesserndem mittel
PE20060459A1 (es) 2004-06-16 2006-05-30 Wyeth Corp DERIVADOS DE AMINO-5,5-DIFENILIMIDAZOLONA COMO INHIBIDORES DE LA ß-SECRETASA
DE602005012825D1 (de) 2004-06-16 2009-04-02 Wyeth Corp Diphenylimidazopyrimidin- und -imidazolamine als b-sekretase-inhibitoren
BRPI0606690A2 (pt) 2005-01-14 2009-07-14 Wyeth Corp composto; uso do composto para o tratamento de uma doença ou distúrbio associado com uma atividade excessiva de bace; e composição farmacêutica
RU2007124935A (ru) 2005-02-01 2009-03-10 Вайет (Us) АМИНОПИРИДИНЫ В КАЧЕСТВЕ ИНГИБИТОРОВ β-СЕКТРЕТАЗЫ
MX2007009864A (es) 2005-02-14 2007-09-04 Wyeth Corp Azolilacilguanidinas como inhibidores de (-secretasa.
WO2006088694A1 (en) 2005-02-14 2006-08-24 Wyeth SUBSTITUTED THIENYL AND FURYL ACYLGUANIDINES AS β-SECRETASE MODULATORS
CN101213183A (zh) 2005-06-30 2008-07-02 惠氏公司 氨基-5-(6元)杂芳基咪唑酮化合物和在β-分泌酶调节中的用途
TW200738683A (en) 2005-06-30 2007-10-16 Wyeth Corp Amino-5-(5-membered)heteroarylimidazolone compounds and the use thereof for β-secretase modulation
CN101273018A (zh) 2005-09-26 2008-09-24 惠氏公司 用于β分泌酶(BACE)抑制剂的氨基-5-[4-(二氟甲氧基)苯基]-5-苯基咪唑酮化合物
WO2007100536A1 (en) 2006-02-24 2007-09-07 Wyeth DIHYDROSPIRO[DIBENZO[A,D][7]ANNULENE-5,4'-IMIDAZOL] COMPOUNDS FOR THE INHIBITION OF β-SECRETASE
US7700606B2 (en) 2006-08-17 2010-04-20 Wyeth Llc Imidazole amines as inhibitors of β-secretase
CL2008000791A1 (es) 2007-03-23 2008-05-30 Wyeth Corp Compuestos derivados de 2-amino-5-(4-difluorometoxi-fenil)-5-fenil-imidazolidin-4-ona; composicion farmaceutica que comprende a dichos compuestos; y su uso en el tratamiento de una enfermedad asociada con la actividad bace excesiva, tales como enferm
WO2018065288A1 (de) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonylmethyl)vinyl]-imidazo[4,5-b]pyridin-derivate und verwandte verbindungen als schädlingsbekämpfungsmittel im pflanzenschutz

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3929582A1 (de) 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DK0556674T3 (da) * 1992-02-15 1996-10-14 Hoechst Ag 3,5-Substituerede benzoylguanidiner med antiarytmisk virkning og inhiberende virkning på celleproliferation
JP3162572B2 (ja) * 1993-04-28 2001-05-08 住友製薬株式会社 インドロイルグアニジン誘導体
US5401758A (en) * 1993-10-07 1995-03-28 Bristol-Myers Squibb Company Pyridinyl cyanoguanidine compounds
DE4430861A1 (de) * 1994-08-31 1996-03-07 Merck Patent Gmbh Heterocyclyl-benzoylguanidine
JPH0959245A (ja) * 1995-08-25 1997-03-04 Yamanouchi Pharmaceut Co Ltd N−(2−プロペノイル)グアニジン誘導体

Also Published As

Publication number Publication date
MX9802238A (es) 1998-08-30
AU702092B2 (en) 1999-02-11
KR19990063589A (ko) 1999-07-26
WO1997011055A1 (en) 1997-03-27
PL326033A1 (en) 1998-08-17
AU7000796A (en) 1997-04-09
CA2232497A1 (en) 1997-03-27
CZ84098A3 (cs) 1998-09-16
CN1196721A (zh) 1998-10-21
BR9610530A (pt) 1999-07-06
SK35198A3 (en) 1999-06-11
ZA967800B (en) 1997-04-03
EP0861831A4 (en) 1998-11-11
HUP9901336A3 (en) 2000-02-28
NO981241D0 (no) 1998-03-19
HUP9901336A2 (hu) 1999-08-30
EP0861831A1 (en) 1998-09-02

Similar Documents

Publication Publication Date Title
NO981241L (no) Heteroarylsubstituerte akryloylguanidinderivater og farmas÷ytiske preparater inneholdende disse
HUP0101999A2 (hu) 4-Hidroxi-kinolin-3-karboxamid- és -hidrazid-származékok, ezeket tartalmazó gyógyászati készítmények, valamint e vegyületek alkalmazása
DK1136474T3 (da) 1-Acetyl-5-brom-4,6-dimethylindolin
ES471981A1 (es) Un procedimiento para la preparacion de derivados de imida- zoquinazolina
NO20004624D0 (no) Benzensulfonamid-derivater og deres anvendelse som medikamenter
FR2401159A1 (fr) Derives de 3-(1h-tetrazol-5-yl)-4h-pyrido(1,2-a)pyrimidine-4-one, leur procede de preparation et leur activite therapeutique
NO963506L (no) 4-Heterocyklyl-substituerte kinazolin-derivater, fremgangsmåte for fremstilling derav og deres anvendelse som anti-kreftmidler
NO2006003I2 (no) ÄR-(R*,R*)Ü-N-Ä3-Ä1-Ä5,6-dihydro-4-hydroksy-2-okso-6-(2-fenyletyl)-6-propyl-2H-pyran-3-ylÜpropylÜfenylÜ5-(trifluormetyl)-2-pyridinsulfonamid eller et farmasotisk salt derav= Tipranavir eller et farmasotisk salt derav
DE59402222D1 (de) Substituierte heterocyclische Carbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
SE8303824D0 (sv) N-imidazolyl derivatives of bicyclic compounds and process for their preparation
DE69019533D1 (de) Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
TNSN87012A1 (fr) Nouveaux derives de dihydrobenzofuranne - et de chromane - carboxamides, leurs procedes de preparation et leur utilisation comme neuroleptiques
NO920432L (no) Cykloalkylenazoler, fremgangsmaate for fremstilling av disse, farmasoeytiske preparater som inneholder disse, saavel som deres anvendelse for fremstilling av legemidler
DE69103630D1 (de) Oxazolederivate, ihre herstellung und diese enthaltende pharmazeutischen zubereitungen.
DK0452204T3 (da) Hidtil ukendte 3-aminochromanderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem
NO20022456L (no) Pyrazolo[1,5-d][1,2,4]triazinerderivater for forbedring av kognisjon
TR199700704A2 (xx) �kame edilmi� indanilidinasetilguanidin'leri, bunlar�n imal edilmesine mahsus usul, bunlar�n ila� ya da diyagnoz maddesi olarak kullan�lmalar� ve bunlar� ihtiva eden ila�lar.
AU7812087A (en) Benzhydryloxyethylpiperidine derivatives, process for their preparation and pharmaceutical compositions in which they are present
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
ATE37368T1 (de) Benzothiazolon-derivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE118346T1 (de) Verwendung von bis(4-hydroxyphenylthio)methan- derivaten zur behandlung von diabetes mellitus.
NO20051833L (no) 4-(3,5-dicyanofenoksy)pyrazolderivater for anvendelse som transkriptasemodulatorer ved behandling av IA HIV.
MY103236A (en) Novel 2-thienyloxyacetic acid derivatives, a process for their preparation and pharmaceutical preparations containing them
DK176788A (da) Thienyloxyeddikesyrederivater, fremgangsmaade til fremstilling af saadanne derivater og laegemiddel indeholdende disse